Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dario Campana

Showing results (1-10 of 130) with videos related to

Pageof 13
Sort By:
Current Hematologic Malignancy Reports|March 1, 2012
Should minimal residual disease monitoring in acute lymphoblastic leukemia be standard of care?Dario Campana
Hematology. American Society of Hematology. Education Program|December 17, 2008
Molecular determinants of treatment response in acute lymphoblastic leukemiaDario Campana
British Journal of Haematology|August 20, 2008
Status of minimal residual disease testing in childhood haematological malignanciesDario Campana
Seminars in Hematology|December 23, 2008
Minimal residual disease in acute lymphoblastic leukemiaDario Campana
Hematology/Oncology Clinics of North America|October 15, 2009
Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemiaDario Campana
Hematology. American Society of Hematology. Education Program|January 18, 2011
Minimal residual disease in acute lymphoblastic leukemiaDario Campana
Current Hematologic Malignancy Reports|April 29, 2010
Role of minimal residual disease evaluation in leukemia therapyDario Campana
Current Hematologic Malignancy Reports|May 15, 2010
Progress of minimal residual disease studies in childhood acute leukemiaDario Campana
American Journal of Clinical Pathology|February 5, 2005
Minimal residual disease studies in acute leukemiaDario Campana
Current Opinion in Hematology|April 25, 2012
Minimal residual disease monitoring in childhood acute lymphoblastic leukemiaDario Campana
Pageof 13

Showing results (1-10 of 130) with videos related to

Sort By:
Pageof 13
Current Hematologic Malignancy Reports|March 1, 2012
Should minimal residual disease monitoring in acute lymphoblastic leukemia be standard of care?Dario Campana
Hematology. American Society of Hematology. Education Program|December 17, 2008
Molecular determinants of treatment response in acute lymphoblastic leukemiaDario Campana
British Journal of Haematology|August 20, 2008
Status of minimal residual disease testing in childhood haematological malignanciesDario Campana
Seminars in Hematology|December 23, 2008
Minimal residual disease in acute lymphoblastic leukemiaDario Campana
Hematology/Oncology Clinics of North America|October 15, 2009
Role of minimal residual disease monitoring in adult and pediatric acute lymphoblastic leukemiaDario Campana
Hematology. American Society of Hematology. Education Program|January 18, 2011
Minimal residual disease in acute lymphoblastic leukemiaDario Campana
Current Hematologic Malignancy Reports|April 29, 2010
Role of minimal residual disease evaluation in leukemia therapyDario Campana
Current Hematologic Malignancy Reports|May 15, 2010
Progress of minimal residual disease studies in childhood acute leukemiaDario Campana
American Journal of Clinical Pathology|February 5, 2005
Minimal residual disease studies in acute leukemiaDario Campana
Current Opinion in Hematology|April 25, 2012
Minimal residual disease monitoring in childhood acute lymphoblastic leukemiaDario Campana
Pageof 13